menu
    • menu

    Company profile for Zelira Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zelira Therapeutics Ltd (formerly Zelda Therapeutics) is a leading global therapeutic medicinal cannabis company with access to the world’s largest and fastest growing cannabis markets. Zelira owns a portfolio of proprietary revenue generating products and a pipeline of candidates undergoing clinical development that are positioned to enter global markets from 2020. The company is focussed on developing branded cannabis prod...
    Zelira Therapeutics Ltd (formerly Zelda Therapeutics) is a leading global therapeutic medicinal cannabis company with access to the world’s largest and fastest growing cannabis markets. Zelira owns a portfolio of proprietary revenue generating products and a pipeline of candidates undergoing clinical development that are positioned to enter global markets from 2020. The company is focussed on developing branded cannabis products for the treatment of a variety of medical conditions. Zelira has launched two proprietary formulations under the HOPE® brand for Autism in multiple US-states with plans to expand into global markets in 2020.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zelira TherapeuticsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 26 140 St Georges Terrace Perth WA 6000
    Telephone
    Telephone
    +61 8 6558 0886
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://zeliratx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clinical trial results of Zelira’s Zenivol published in the SLEEP journal
    Clinical trial results of Zelira’s Zenivol published in the SLEEP journal

    21 Jun 2021

    // PROACTIVEINVESTORS

    https://www.proactiveinvestors.com.au/companies/news/952750/zelira-therapeutics-has-clinical-trial-results-of-zenivol-published-in-sleep-952750.html

    PROACTIVEINVESTORS
    21 Jun 2021
    Share Share
    Breakthrough Research Demonstrates Significant Uptake of CBD Into the Brain
    Breakthrough Research Demonstrates Significant Uptake of CBD Into the Brain

    18 Jun 2021

    // PRESS RELEASE

    https://company-announcements.afr.com/asx/zld/8b4ba539-cfc5-11eb-9a3c-7214c9d6efac.pdf

    PRESS RELEASE
    18 Jun 2021
    Share Share
    ZELIRA THERAPEUTICS AND LEVIN HEALTH ENTER LICENSING AND MANAGEMENT AGREEMENT
    ZELIRA THERAPEUTICS AND LEVIN HEALTH ENTER LICENSING AND MANAGEMENT AGREEMENT

    07 Jun 2021

    // PROACTIVE

    https://www.proactiveinvestors.com.au/companies/news/951250/zelira-therapeutics-teams-up-with-levin-health-to-trial-cannabinoid-treatment-for-chronic-pain-in-retired-athletes-951250.html

    PROACTIVE
    07 Jun 2021
    Share Share
    Zelira Therapeutics’ cannabis trial meets goals for insomnia
    Zelira Therapeutics’ cannabis trial meets goals for insomnia

    08 Apr 2020

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/zelira-therapeutics-cannabis-trial-data/

    CLINICALTRIALSARENA
    08 Apr 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search